219 related articles for article (PubMed ID: 24133978)
1. [Synthesis and antitumor activity of novel tetrahydro-beta-carboline derivatives as KSP inhibitors].
Ruan XQ; Chen M; Wu WT; You QD
Yao Xue Xue Bao; 2013 Jul; 48(7):1119-23. PubMed ID: 24133978
[TBL] [Abstract][Full Text] [Related]
2. Discovery of tetrahydro-beta-carbolines as inhibitors of the mitotic kinesin KSP.
Liu F; Yu LQ; Jiang C; Yang L; Wu WT; You QD
Bioorg Med Chem; 2010 Jun; 18(12):4167-77. PubMed ID: 20537544
[TBL] [Abstract][Full Text] [Related]
3. [Synthesis and biological evaluation of tetrahydro-beta-carline derivatives].
Ruan XQ; You QD; Yang L; Wu WT
Yao Xue Xue Bao; 2008 Aug; 43(8):828-32. PubMed ID: 18956775
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel 3,9-substituted β-carboline derivatives as anticancer agents.
Chen YF; Lin YC; Chen JP; Chan HC; Hsu MH; Lin HY; Kuo SC; Huang LJ
Bioorg Med Chem Lett; 2015 Sep; 25(18):3873-7. PubMed ID: 26235951
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of carboline and carbazole derivatives as a novel class of ATP-competitive kinesin spindle protein inhibitors.
Takeuchi T; Oishi S; Watanabe T; Ohno H; Sawada J; Matsuno K; Asai A; Asada N; Kitaura K; Fujii N
J Med Chem; 2011 Jul; 54(13):4839-46. PubMed ID: 21599002
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of new tetrahydro-beta-carbolines as inhibitors of the mitotic kinesin Eg5.
Sunder-Plassmann N; Sarli V; Gartner M; Utz M; Seiler J; Huemmer S; Mayer TU; Surrey T; Giannis A
Bioorg Med Chem; 2005 Nov; 13(22):6094-111. PubMed ID: 16084101
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of some β-carboline derivatives as multi-target anticancer agents.
Abdelsalam MA; AboulWafa OM; Badawey EA; El-Shoukrofy MS; El-Miligy MM; Gouda N
Future Med Chem; 2018 Dec; 10(24):2791-2814. PubMed ID: 30539666
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and in vitro and in vivo antitumor activities of novel beta-carboline derivatives.
Cao R; Chen H; Peng W; Ma Y; Hou X; Guan H; Liu X; Xu A
Eur J Med Chem; 2005 Oct; 40(10):991-1001. PubMed ID: 15950325
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, anticancer screening, docking studies and in silico ADME prediction of some β-carboline derivatives.
Abdelsalam MA; AboulWafa OM; M Badawey EA; El-Shoukrofy MS; El-Miligy MM; Gouda N; Elaasser MM
Future Med Chem; 2018 May; 10(10):1159-1175. PubMed ID: 29787297
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, biological evaluation and molecular docking studies of flavone and isoflavone derivatives as a novel class of KSP (kinesin spindle protein) inhibitors.
Dong JJ; Li QS; Liu ZP; Wang SF; Zhao MY; Yang YH; Wang XM; Zhu HL
Eur J Med Chem; 2013; 70():427-33. PubMed ID: 24184776
[TBL] [Abstract][Full Text] [Related]
11. [Synthesis and antitumor activities of 1-(4-chlorophenyl)-beta-carboline derivatives].
Ma Q; Guo L; Sun J; Fan WX
Yao Xue Xue Bao; 2013 Jan; 48(1):77-82. PubMed ID: 23600145
[TBL] [Abstract][Full Text] [Related]
12. Syntheses of novel β-carboline derivatives and the activities against five tumor-cell lines.
Bai B; Li XY; Liu L; Li Y; Zhu HJ
Bioorg Med Chem Lett; 2014 Jan; 24(1):96-8. PubMed ID: 24345445
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antitumor activity of β-carboline 3-(substituted-carbohydrazide) derivatives.
Barbosa VA; Formagio AS; Savariz FC; Foglio MA; Spindola HM; de Carvalho JE; Meyer E; Sarragiotto MH
Bioorg Med Chem; 2011 Nov; 19(21):6400-8. PubMed ID: 21944971
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and In Vitro Antitumor Activity of Novel Bivalent
Gu H; Li N; Dai J; Xi Y; Wang S; Wang J
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30326662
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of novel hybrids β-carboline-4-thiazolidinones as potential antitumor and antiviral agents.
Barbosa VA; Baréa P; Mazia RS; Ueda-Nakamura T; Costa WFD; Foglio MA; Goes Ruiz ALT; Carvalho JE; Vendramini-Costa DB; Nakamura CV; Sarragiotto MH
Eur J Med Chem; 2016 Nov; 124():1093-1104. PubMed ID: 27792980
[TBL] [Abstract][Full Text] [Related]
16. New 3-tetrazolyl-β-carbolines and β-carboline-3-carboxylates with anti-cancer activity.
Panice MR; Lopes SMM; Figueiredo MC; Goes Ruiz ALT; Foglio MA; Nazari Formagio AS; Sarragiotto MH; Pinho E Melo TMVD
Eur J Med Chem; 2019 Oct; 179():123-132. PubMed ID: 31247374
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationships of asymmetric dimeric β-carboline derivatives as potential antitumor agents.
Guo L; Chen W; Cao R; Fan W; Ma Q; Zhang J; Dai B
Eur J Med Chem; 2018 Mar; 147():253-265. PubMed ID: 29448140
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitumoral activity of novel 3-(2-substituted-1,3,4-oxadiazol-5-yl) and 3-(5-substituted-1,2,4-triazol-3-yl) beta-carboline derivatives.
Formagio AS; Tonin LT; Foglio MA; Madjarof C; de Carvalho JE; da Costa WF; Cardoso FP; Sarragiotto MH
Bioorg Med Chem; 2008 Nov; 16(22):9660-7. PubMed ID: 18951806
[TBL] [Abstract][Full Text] [Related]
19. The preparation and evaluation of 1-substituted 1,2,3,4-tetrahydro- and 3,4-dihydro-beta-carboline derivatives as potential antitumor agents.
Shen YC; Chen CY; Hsieh PW; Duh CY; Lin YM; Ko CL
Chem Pharm Bull (Tokyo); 2005 Jan; 53(1):32-6. PubMed ID: 15635225
[TBL] [Abstract][Full Text] [Related]
20. Design of beta-carboline derivatives as DNA-targeting antitumor agents.
Guan H; Chen H; Peng W; Ma Y; Cao R; Liu X; Xu A
Eur J Med Chem; 2006 Oct; 41(10):1167-79. PubMed ID: 16790297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
